2026-07-24 2026-07-24 , online online, 690 € zzgl. MwSt. Kristie Champlin Gurley https://www.forum-institut.de/seminar/26112201-us-mfn-drug-pricing-european-market-access-strategic-briefing-for-2027/referenten/26/26_11/26112201-most-favored-nation-mfn_gurley-kristie-champlin.jpg US MFN Drug Pricing & European Market Access: Strategic Briefing for 2027

The US Most Favored Nation policy is already reshaping pharmaceutical pricing in Europe. Kristie Champlin Gurley, formerly with the US Department of Health and Human Services where she advised directly on the CMS drug pricing portfolio, brings first-hand regulatory insight into how GUARD and GLOBE were designed. Leave with concrete strategic orientation for 2027.

Topics
  • Political background and evolution of MFN thinking
  • GUARD and GLOBE in detail: objectives, scope, design features, similarities and differences, proposed timelines and implementation pathways
  • MFN and European pricing fundamentals: interaction with national pricing and reimbursement systems, consequences for confidential discounts and managed entry agreements
  • Global market launch sequence: how is MFN changing it?


Who should attend
This seminar is aimed at professionals in the pharmaceutical and biotech industry responsible for pricing, market access and reimbursement.

Participants should be familiar with the fundamentals of International Reference Pricing (IRP). Prior knowledge of GUARD and GLOBE is not required.
Aims and objectives
This online seminar provides pricing, market access and regulatory professionals with a structured and expert-guided overview of the current MFN policy landscape and its direct consequences for European pharmaceutical pricing. Participants gain a clear understanding of the proposed GUARD and GLOBE models, their interaction with International Reference Pricing, and the strategic implications for global launch sequencing ahead of 2027.
Your benefit

  • You understand the full MFN toolkit and how the proposed GUARD and GLOBE models are designed to interact with existing pricing and reimbursement frameworks.
  • You assess the potential impact of MFN on European net prices, confidential discounts and managed entry agreements before the relevant deadlines.
  • You can evaluate how MFN possibly changes the logic of global market launch sequencing and what strategic adjustments may be required.
  • You leave with orientation for your pricing and market access planning for 2027.

Most Favored Nation (MFN) Principle - Focus Pharma

US MFN Drug Pricing & European Market Access: Strategic Briefing for 2027

Benefits
  • First-hand insights from a former HHS insider
  • Strategic guidance for global pharma decisions
  • Officially certified according to ISO 9001 and ISO 21001

Webcode 26112201

Jetzt buchen

JETZT Buchen

Referenten


Alles auf einen Blick

Termin

19/11/2026

19/11/2026

Zeitraum

02:00 p.m. - 05:00 p.m.

02:00 p.m. - 05:00 p.m.
Veranstaltungsort

online

online

Downloads
Gebühr
Your contact

Leila Dörfler
Team Leader

+49 6221 500-695
l.doerfler@forum-institut.de

Details

The US Most Favored Nation policy is already reshaping pharmaceutical pricing in Europe. Kristie Champlin Gurley, formerly with the US Department of Health and Human Services where she advised directly on the CMS drug pricing portfolio, brings first-hand regulatory insight into how GUARD and GLOBE were designed. Leave with concrete strategic orientation for 2027.

Topics

  • Political background and evolution of MFN thinking
  • GUARD and GLOBE in detail: objectives, scope, design features, similarities and differences, proposed timelines and implementation pathways
  • MFN and European pricing fundamentals: interaction with national pricing and reimbursement systems, consequences for confidential discounts and managed entry agreements
  • Global market launch sequence: how is MFN changing it?


Who should attend
This seminar is aimed at professionals in the pharmaceutical and biotech industry responsible for pricing, market access and reimbursement.

Participants should be familiar with the fundamentals of International Reference Pricing (IRP). Prior knowledge of GUARD and GLOBE is not required.

Aims and objectives

This online seminar provides pricing, market access and regulatory professionals with a structured and expert-guided overview of the current MFN policy landscape and its direct consequences for European pharmaceutical pricing. Participants gain a clear understanding of the proposed GUARD and GLOBE models, their interaction with International Reference Pricing, and the strategic implications for global launch sequencing ahead of 2027.

Your benefit

  • You understand the full MFN toolkit and how the proposed GUARD and GLOBE models are designed to interact with existing pricing and reimbursement frameworks.
  • You assess the potential impact of MFN on European net prices, confidential discounts and managed entry agreements before the relevant deadlines.
  • You can evaluate how MFN possibly changes the logic of global market launch sequencing and what strategic adjustments may be required.
  • You leave with orientation for your pricing and market access planning for 2027.

Detailed programme

02:00 p.m. - 05:00 p.m.

14:00 Welcome and introduction


14:15

Kristie Champlin Gurley

The global MFN landscape towards 2027
  • Political background: evolution of MFN thinking in key markets, from national initiatives to coordinated international approaches
  • MFN toolkit overview: types of MFN clauses and mechanisms, interaction with price agreements, discounts and data transparency
  • Deep dive: GUARD and GLOBE, objectives, scope, design features, similarities and differences, expected timelines and implementation pathways
  • Further geopolitical deals and initiatives

15:15 Break


15:30

Dr. Dr. Adem Koyuncu

What MFN means for European pricing and International Reference Pricing
  • MFN and European pricing fundamentals: interaction with national pricing and reimbursement systems, consequences for confidential discounts and managed entry agreements
  • Impact on International Reference Pricing (IRP): how MFN provisions may amplify IRP effects, risk of price spillover and unintended reference chains

16:15

Dr. Sebastian Werner

Global market launch sequence - how is MFN changing it? What needs to change in the EU?

17:00 End


Ihr Nutzen

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

Access to and procedure for online events

Once you have registered for an event, we will send you the access information for your customer portal. Click here to log in to the customer portal using your email address and password. Please ensure you can access the customer portal before the day of the event.

All important or additional information and personal documents are available in your personalised customer portal. This is also where you start your online courses. If you do not have access to the customer portal yet, you can easily register here.

On the day of the event, you kick off your online training in the customer portal by clicking ‘Participate’ directly in the respective event. You will then be redirected to the Learning Space.

Learn more about our online events here.

This distinguishes our events

of 5 stars of all ratings from 2025

of 5 stars on Trustpilot = good

Recommendations

Erstattung von Medizinprodukten in der Praxis

Erfahren Sie in unserem praxisnahen Seminar, wie Sie die Erstattung von Medizinprodukten erfolgreich gestalten. Profitie...

24.08.2026 in
Details

Leveraging AI in Evidence Generation and Market Access

Using AI for clinical data evaluation, systematic literature reviews, dossier writing, and PICO simulations - the essent...

14.10.2026 in
Details

ExpertFORUM Global Regulatory Affairs

This online conference offers compact expert talks and diverse perspectives on global regulatory strategies, digital tra...

17. - 18.09.2026 in
Details

Generika und Biosimilars in Rabattverträgen und Ausschreibungen

Das Seminar vermittelt Ihnen einen kompakten Überblick über aktuelle rechtliche Vorgaben, Ausschreibungsverfahren und st...

30.09.2026 in
Details

Healthcare Management & Market Access-Lehrgang

In 2 Lehrgangstagen erhalten Sie profundes gesundheitspolitisches und gesundheitsökonomisches Know-how sowie Praxiswisse...

26. - 27.08.2026 in
Details

Go forward

e-Learning - Click and learn

We provide flexible education and training with high-quality e-Learning programmes for several topics.

Details
e-Learning
List of abbreviations pharma & healthcare

Many abbreviations are used in pharma & healthcare. Download the list of the most important ones.

Details
Abbreviations, Glossary
Our rating in 2025

More than 3,700 customers have rated our training courses. Thank you for awarding us 4.4 stars out of 5.

Details
Our rating in 2025